145 related articles for article (PubMed ID: 26345688)
1. Contraceptive practices and cervical screening in women with cystic fibrosis.
Rousset Jablonski C; Reynaud Q; Perceval M; Nove-Josserand R; Durupt S; Lega JC; Durieu I
Hum Reprod; 2015 Nov; 30(11):2547-51. PubMed ID: 26345688
[TBL] [Abstract][Full Text] [Related]
2. Improvement in contraceptive coverage and gynecological care of adult women with cystic fibrosis following the implementation of an on-site gynecological consultation.
Rousset-Jablonski C; Reynaud Q; Perceval M; Nove-Josserand R; Durupt S; Ray-Coquard I; Golfier F; Durieu I
Contraception; 2020 Mar; 101(3):183-188. PubMed ID: 31786201
[TBL] [Abstract][Full Text] [Related]
3. Provision of contraception services and advice for women with cystic fibrosis.
Gatiss S; Mansour D; Doe S; Bourke S
J Fam Plann Reprod Health Care; 2009 Jul; 35(3):157-60. PubMed ID: 19622205
[TBL] [Abstract][Full Text] [Related]
4. High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosis.
Rousset-Jablonski C; Reynaud Q; Nove-Josserand R; Ray-Coquard I; Mekki Y; Golfier F; Durieu I;
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():40-45. PubMed ID: 29245055
[TBL] [Abstract][Full Text] [Related]
5. Contraceptive choices and preferences in a cohort of women with cystic fibrosis.
Roe AH; Traxler SA; Hadjiliadis D; Sammel MD; Schreiber CA
Respir Med; 2016 Dec; 121():1-3. PubMed ID: 27888982
[TBL] [Abstract][Full Text] [Related]
6. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
7. Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient Registry.
Godfrey EM; Mody S; Schwartz MR; Heltshe SL; Taylor-Cousar JL; Jain R; Sufian S; Josephy T; Aitken ML
Contraception; 2020 Jun; 101(6):420-426. PubMed ID: 32109430
[TBL] [Abstract][Full Text] [Related]
8. Midwives' adoption of the reproductive life plan in contraceptive counselling: a mixed methods study.
Stern J; Bodin M; Grandahl M; Segeblad B; Axén L; Larsson M; Tydén T
Hum Reprod; 2015 May; 30(5):1146-55. PubMed ID: 25771220
[TBL] [Abstract][Full Text] [Related]
9. [Gynecological management and follow-up in women with cystic fibrosis].
Rousset-Jablonski C; Reynaud Q; Nove-Josserand R; Durupt S; Durieu I
Rev Mal Respir; 2018 Jun; 35(6):592-603. PubMed ID: 29958717
[TBL] [Abstract][Full Text] [Related]
10. Determinants of cervical Chlamydia trachomatis infection in Italy. The Italian MEGIC Group.
Genitourin Med; 1993 Apr; 69(2):123-5. PubMed ID: 8509092
[TBL] [Abstract][Full Text] [Related]
11. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
[TBL] [Abstract][Full Text] [Related]
12. Introducing reproductive life plan-based information in contraceptive counselling: an RCT.
Stern J; Larsson M; Kristiansson P; Tydén T
Hum Reprod; 2013 Sep; 28(9):2450-61. PubMed ID: 23842564
[TBL] [Abstract][Full Text] [Related]
13. Contraceptive safety among women with cystic fibrosis: a systematic review.
Whiteman MK; Oduyebo T; Zapata LB; Walker S; Curtis KM
Contraception; 2016 Dec; 94(6):621-629. PubMed ID: 27287694
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
15. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
[TBL] [Abstract][Full Text] [Related]
16. The relevance of ethnic monitoring in the experience of Haringey Healthcare NHS trust community family planning clinics.
Christopher E
Br J Fam Plann; 1999 Jan; 24(4):123-7. PubMed ID: 10023096
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
18. Cervical Cancer Screening, Pelvic Examinations, and Contraceptive Use Among Adolescent and Young Adult Females.
Vinekar KS; Vahratian A; Hall KS; West BT; Caldwell A; Bell JD; Dalton VK
J Adolesc Health; 2015 Aug; 57(2):169-73. PubMed ID: 26026477
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of Chlamydia trachomatis in a young, sexually-active population.
Kovacs GT; Westcott M; Rusden J; Asche V; King H; Haynes SE; Moore EK; Ketelbey JW
Med J Aust; 1987 Dec 7-21; 147(11-12):550-2. PubMed ID: 3501060
[TBL] [Abstract][Full Text] [Related]
20. Young Singaporean women's knowledge of cervical cancer and pap smear screening: a descriptive study.
Shea J; Klainin-Yobas P; Mackey S
J Clin Nurs; 2013 Dec; 22(23-24):3310-9. PubMed ID: 24580785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
